# EchoStar CORP: financial statements, quarterly ECHO · Nasdaq · CIK 1415404 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/echo.md) · [Financials](/companies/echo/financials.md) · [Filings](/companies/echo/filings.md) · [Insiders](/companies/echo/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/echo/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [4.1](/filings/0001558370-24-015122.md) | [4.2](/filings/0001558370-24-002209.md) | [4.0](/filings/0001558370-25-007050.md) | [4.0](/filings/0001558370-25-009923.md) | [3.9](/filings/0001104659-25-107277.md) | [4.0 d](/filings/0001104659-26-021817.md) | [3.9](/filings/0001104659-26-058150.md) | [3.7](/filings/0001104659-26-089370.md) | [3.6](/filings/0001104659-25-107277.md) | [3.8 d](/filings/0001104659-26-021817.md) | [3.7](/filings/0001104659-26-058150.md) | [3.6](/filings/0001104659-26-089370.md) | | Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Research and development | $bn | [0.0](/filings/0001558370-24-015122.md) | [0.0 d](/filings/0001104659-26-021817.md) | [0.0](/filings/0001558370-25-007050.md) | [0.0](/filings/0001558370-25-009923.md) | [0.0](/filings/0001104659-25-107277.md) | [0.0 d](/filings/0001104659-26-021817.md) | [0.0](/filings/0001104659-26-058150.md) | [0.0](/filings/0001104659-26-089370.md) | [0.0](/filings/0001104659-25-107277.md) | [0.0 d](/filings/0001104659-26-021817.md) | [0.0](/filings/0001104659-26-058150.md) | [0.0](/filings/0001104659-26-089370.md) | | Selling, general and administrative | $bn | [0.8](/filings/0001558370-24-015122.md) | [0.8 d](/filings/0001104659-26-021817.md) | [0.6](/filings/0001558370-25-007050.md) | [0.6](/filings/0001558370-25-009923.md) | [0.6](/filings/0001104659-25-107277.md) | [0.6 d](/filings/0001104659-26-021817.md) | [0.6](/filings/0001104659-26-058150.md) | [0.6](/filings/0001104659-26-089370.md) | [0.6](/filings/0001104659-25-107277.md) | [0.5 d](/filings/0001104659-26-021817.md) | [0.6](/filings/0001104659-26-058150.md) | [0.5](/filings/0001104659-26-089370.md) | | Operating income | $bn | [(0.0)](/filings/0001558370-24-015122.md) | [(0.9)](/filings/0001558370-24-002209.md) | [(0.0)](/filings/0001558370-25-007050.md) | [(0.1)](/filings/0001558370-25-009923.md) | [(0.2)](/filings/0001104659-25-107277.md) | [(0.1) d](/filings/0001104659-26-021817.md) | [(0.1)](/filings/0001104659-26-058150.md) | [(0.2)](/filings/0001104659-26-089370.md) | [(16.6)](/filings/0001104659-25-107277.md) | [(0.8) d](/filings/0001104659-26-021817.md) | [0.4](/filings/0001104659-26-058150.md) | [0.5](/filings/0001104659-26-089370.md) | | Interest expense | $bn | [0.0](/filings/0001415404-23-000020.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $bn | [(0.1)](/filings/0001558370-24-015122.md) | [(0.4) d](/filings/0001104659-26-021817.md) | [(0.0)](/filings/0001558370-25-007050.md) | [(0.0)](/filings/0001558370-25-009923.md) | [(0.0)](/filings/0001104659-25-107277.md) | [0.1 d](/filings/0001104659-26-021817.md) | [(0.1)](/filings/0001104659-26-058150.md) | [(0.1)](/filings/0001104659-26-089370.md) | [(4.2)](/filings/0001104659-25-107277.md) | [(0.1) d](/filings/0001104659-26-021817.md) | [(0.0)](/filings/0001104659-26-058150.md) | [1.3](/filings/0001104659-26-089370.md) | | Net income | $bn | [(0.1)](/filings/0001558370-24-015122.md) | [(2.0)](/filings/0001558370-24-002209.md) | [(0.1)](/filings/0001104659-25-107277.md) | [(0.2)](/filings/0001104659-25-107277.md) | [(0.1)](/filings/0001104659-25-107277.md) | [0.3 d](/filings/0001104659-26-021817.md) | [(0.2)](/filings/0001104659-26-089370.md) | [(0.3)](/filings/0001104659-26-089370.md) | [(12.8)](/filings/0001104659-25-107277.md) | [(1.2) d](/filings/0001104659-26-021817.md) | [(0.1)](/filings/0001104659-26-089370.md) | [8.5](/filings/0001104659-26-089370.md) | | Diluted EPS | $ per share | [(0.51)](/filings/0001558370-24-015122.md) | [(7.48)](/filings/0001558370-24-002209.md) | [(0.40)](/filings/0001558370-25-007050.md) | [(0.76)](/filings/0001558370-25-009923.md) | [(0.52)](/filings/0001104659-25-107277.md) | not reported | [(0.71)](/filings/0001104659-26-058150.md) | [(1.06)](/filings/0001104659-26-089370.md) | [(44.37)](/filings/0001104659-25-107277.md) | not reported | [(0.51)](/filings/0001104659-26-058150.md) | [24.12](/filings/0001104659-26-089370.md) | | Basic EPS | $ per share | [(0.51)](/filings/0001558370-24-015122.md) | [(7.48)](/filings/0001558370-24-002209.md) | [(0.40)](/filings/0001558370-25-007050.md) | [(0.76)](/filings/0001558370-25-009923.md) | [(0.52)](/filings/0001104659-25-107277.md) | not reported | [(0.71)](/filings/0001104659-26-058150.md) | [(1.06)](/filings/0001104659-26-089370.md) | [(44.37)](/filings/0001104659-25-107277.md) | not reported | [(0.51)](/filings/0001104659-26-058150.md) | [29.17](/filings/0001104659-26-089370.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: not reported - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-11-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [1.8](/filings/0001558370-25-001663.md) | [0.6](/filings/0001558370-24-007171.md) | [0.4](/filings/0001558370-24-011672.md) | [0.6](/filings/0001558370-24-015122.md) | not reported | [4.3](/filings/0001104659-26-021817.md) | [2.5](/filings/0001558370-25-007050.md) | [2.3](/filings/0001558370-25-009923.md) | [2.4](/filings/0001104659-25-107277.md) | [1.9](/filings/0001104659-26-089370.md) | [1.3](/filings/0001104659-26-058150.md) | [0.4](/filings/0001104659-26-089370.md) | | Current assets | $bn | [4.9](/filings/0001558370-25-001663.md) | [3.1](/filings/0001558370-24-007171.md) | [2.8](/filings/0001558370-24-011672.md) | [5.0](/filings/0001558370-24-015122.md) | not reported | [8.1](/filings/0001104659-26-021817.md) | [7.6](/filings/0001558370-25-007050.md) | [6.9](/filings/0001558370-25-009923.md) | [6.0](/filings/0001104659-25-107277.md) | [5.1](/filings/0001104659-26-089370.md) | [3.5](/filings/0001104659-26-058150.md) | [19.9](/filings/0001104659-26-089370.md) | | Total assets | $bn | [57.1](/filings/0001558370-25-001663.md) | [55.6](/filings/0001558370-24-007171.md) | [55.3](/filings/0001558370-24-011672.md) | [57.5](/filings/0001558370-24-015122.md) | not reported | [60.9](/filings/0001104659-26-021817.md) | [60.6](/filings/0001558370-25-007050.md) | [59.9](/filings/0001558370-25-009923.md) | [45.3](/filings/0001104659-25-107277.md) | [43.0](/filings/0001104659-26-089370.md) | [41.4](/filings/0001104659-26-058150.md) | [39.4](/filings/0001104659-26-089370.md) | | Current liabilities | $bn | [8.0](/filings/0001558370-25-001663.md) | [7.0](/filings/0001558370-24-007171.md) | [7.0](/filings/0001558370-24-011672.md) | [7.5](/filings/0001558370-24-015122.md) | not reported | [5.8](/filings/0001104659-26-021817.md) | [6.1](/filings/0001558370-25-007050.md) | [5.7](/filings/0001558370-25-009923.md) | [10.0](/filings/0001104659-25-107277.md) | [12.4](/filings/0001104659-26-089370.md) | [11.8](/filings/0001104659-26-058150.md) | [3.8](/filings/0001104659-26-089370.md) | | Total liabilities | $bn | [36.7](/filings/0001558370-25-001663.md) | [35.7](/filings/0001558370-24-007171.md) | [35.6](/filings/0001558370-24-011672.md) | [38.0](/filings/0001558370-24-015122.md) | not reported | [40.7](/filings/0001104659-26-021817.md) | [40.5](/filings/0001558370-25-007050.md) | [40.1](/filings/0001558370-25-009923.md) | [38.3](/filings/0001104659-25-107277.md) | [37.2](/filings/0001104659-26-089370.md) | [35.7](/filings/0001104659-26-058150.md) | [25.2](/filings/0001104659-26-089370.md) | | Long-term debt | $bn | not reported | [1.0](/filings/0001558370-24-002209.md) | not reported | not reported | [2.0](/filings/0001558370-24-015122.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $bn | [19.9](/filings/0001558370-25-001663.md) | [19.8](/filings/0001558370-24-007171.md) | [19.6](/filings/0001558370-24-011672.md) | [19.4](/filings/0001558370-24-015122.md) | not reported | [20.2](/filings/0001104659-26-021817.md) | [20.0](/filings/0001558370-25-007050.md) | [19.7](/filings/0001558370-25-009923.md) | [7.0](/filings/0001104659-25-107277.md) | [5.8](/filings/0001104659-26-089370.md) | [5.6](/filings/0001104659-26-058150.md) | [14.2](/filings/0001104659-26-089370.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [482 d](/filings/0001558370-24-015122.md) | [411 d](/filings/0001104659-26-021817.md) | [451](/filings/0001558370-25-007050.md) | [480 d](/filings/0001558370-25-009923.md) | [276 d](/filings/0001104659-25-107277.md) | [45.6 d](/filings/0001104659-26-021817.md) | [207](/filings/0001104659-26-058150.md) | [7.5 d](/filings/0001104659-26-089370.md) | [112 d](/filings/0001104659-25-107277.md) | [(425) d](/filings/0001104659-26-021817.md) | [238](/filings/0001104659-26-058150.md) | [(10.0) d](/filings/0001104659-26-089370.md) | | Capital expenditure | $m | [833 d](/filings/0001558370-24-015122.md) | [567 d](/filings/0001104659-26-021817.md) | [520](/filings/0001558370-25-007050.md) | [347 d](/filings/0001558370-25-009923.md) | [334 d](/filings/0001104659-25-107277.md) | [344 d](/filings/0001104659-26-021817.md) | [258](/filings/0001104659-26-058150.md) | [293 d](/filings/0001104659-26-089370.md) | [256 d](/filings/0001104659-25-107277.md) | [158 d](/filings/0001104659-26-021817.md) | [133](/filings/0001104659-26-058150.md) | [92.3 d](/filings/0001104659-26-089370.md) | | Share repurchases | $m | [0.0 d](/filings/0001415404-23-000020.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-26-021817.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [83.1](/filings/0001415404-23-000020.md) | [0.3](/filings/0001558370-24-007171.md) | [0.3](/filings/0001558370-24-011672.md) | [0.3](/filings/0001558370-24-015122.md) | [0.3](/filings/0001558370-25-007050.md) | [0.3](/filings/0001558370-25-009923.md) | [0.3](/filings/0001104659-25-107277.md) | [287](/filings/0001104659-26-058150.md) | [288](/filings/0001104659-26-089370.md) | [0.3](/filings/0001104659-25-107277.md) | [289](/filings/0001104659-26-058150.md) | [352](/filings/0001104659-26-089370.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.